Preventing Mother-to-Child HIV Transmission: Strategies and Solutions

Every year, approximately 1.3 million women and girls living with HIV become pregnant globally. Without intervention, transmission rates from mother to child range from 15% to 45% during pregnancy, labor, delivery, or breastfeeding. However, comprehensive prevention strategies have dramatically reduced these rates. With proper interventions, transmission can be lowered to less than 2% in high-resource settings and below 5% in many other contexts. Understanding these prevention strategies is essential for protecting the next generation from HIV.

Protecting women before pregnancy 🔗

The foundation of preventing mother-to-child transmission begins with preventing HIV infection in women of reproductive age. Primary prevention focuses on education about safe sexual practices, consistent condom use, and limiting the number of sexual partners. Access to comprehensive sexual health information empowers women to make informed decisions about their reproductive health.

Treatment of sexually transmitted infections plays a crucial role in HIV prevention. STIs can increase susceptibility to HIV infection, making their prompt diagnosis and treatment an important preventive measure. Health systems must integrate HIV prevention into sexual and reproductive health services, ensuring women have access to contraceptive counseling and family planning services. For women already living with HIV, preventing unintended pregnancies becomes a key strategy, allowing them to plan pregnancies when their health status is optimal.

Early detection through counseling and testing 🔗

Voluntary HIV counseling and testing represents a critical entry point for prevention services. Early detection allows women to access treatment and care before or during pregnancy, significantly reducing transmission risk. Global testing coverage has expanded dramatically, with an increasing number of pregnant women in low- and middle-income countries now knowing their HIV status through antenatal care or prior testing.

The importance of partner testing 🔗

Testing should extend beyond the pregnant woman to include her partner. Partner involvement in HIV testing and counseling improves outcomes throughout the prevention cascade. When partners know their HIV status, couples can make informed decisions together about prevention strategies, treatment adherence, and infant feeding choices. Male partner involvement has been shown to reduce infant HIV transmission rates and improve retention in care.

Repeat testing during pregnancy 🔗

A single HIV test during pregnancy may not be sufficient. Women can acquire HIV during pregnancy or breastfeeding, a period when they may be particularly vulnerable to new infections. Health authorities recommend repeat testing at various points during pregnancy and the postpartum period, especially in settings with high HIV prevalence. This approach helps identify women who may have recently acquired the infection and ensures they receive timely interventions.

Antiretroviral therapy as the cornerstone 🔗

Antiretroviral therapy has transformed the landscape of mother-to-child transmission prevention. When mothers receive ART during pregnancy, labor, and breastfeeding, transmission risks decrease substantially. Current WHO guidelines recommend lifelong ART for all pregnant and breastfeeding women living with HIV, regardless of their CD4 count or clinical stage.

How antiretrovirals work 🔗

ARVs work by suppressing the amount of virus in the mother’s blood and body fluids, including breast milk. When viral load becomes undetectable, the risk of transmission drops dramatically. The medications are given to the mother during pregnancy and continued throughout breastfeeding. In some cases, infants also receive prophylactic ARVs for several weeks after birth, providing an additional layer of protection.

Timing and adherence matter 🔗

The effectiveness of ART depends heavily on when treatment begins and how consistently it’s taken. Starting treatment early in pregnancy, or ideally before conception, allows time for viral suppression before delivery. Adherence to medication regimens is crucial throughout pregnancy and breastfeeding. Even brief interruptions in treatment can allow viral rebound, increasing transmission risk. Support systems that help women stay on treatment, including counseling and addressing barriers to medication access, are essential components of successful prevention programs.

Navigating infant feeding choices 🔗

Infant feeding decisions represent one of the most challenging aspects of preventing mother-to-child transmission. The guidance has evolved significantly as evidence has accumulated about the protective effects of maternal ART during breastfeeding.

Breastfeeding with antiretroviral protection 🔗

In many settings, particularly where access to clean water and affordable formula is limited, WHO recommends that mothers living with HIV exclusively breastfeed for the first six months while taking ART. Exclusive breastfeeding means giving only breast milk with no other liquids or foods, which carries lower transmission risk than mixed feeding. Mothers can continue breastfeeding for 12 to 24 months or longer while maintaining viral suppression through ART.

The benefits of breastfeeding extend beyond nutrition. Breast milk provides antibodies and other protective factors that help infants fight infections, reduce diarrheal diseases, and support healthy development. In resource-limited settings where infant mortality from malnutrition and infectious diseases remains high, these benefits often outweigh the small residual risk of HIV transmission when mothers are on effective ART.

Formula feeding as an alternative 🔗

In high-resource settings where safe alternatives are readily available, formula feeding eliminates the risk of postnatal HIV transmission. Properly prepared infant formula or pasteurized donor human milk from milk banks can provide adequate nutrition without exposure to HIV through breast milk. However, this option requires consistent access to clean water, reliable electricity for sterilization, and financial resources to purchase formula.

Recent guidelines in some high-resource countries have shifted toward shared decision-making, where healthcare providers counsel mothers about both replacement feeding and breastfeeding options. This patient-centered approach recognizes that mothers may weigh multiple factors including cultural practices, social circumstances, and personal preferences when making feeding decisions.

The essential role of community support 🔗

Individual medical interventions alone cannot eliminate mother-to-child transmission. Community involvement and social support systems play indispensable roles in successful prevention programs. Stigma and discrimination continue to discourage women from seeking HIV testing, disclosing their status, and accessing treatment services. Community education helps create supportive environments where women feel safe accessing prevention services.

Peer support and mentorship 🔗

Programs that connect mothers living with HIV with peer mentors have shown positive impacts on retention in care and treatment adherence. Women who have successfully navigated pregnancy and infant feeding while living with HIV can provide practical guidance and emotional support to others facing similar circumstances. These peer relationships help reduce isolation and provide real-world strategies for overcoming barriers to care.

Addressing structural barriers 🔗

Communities must work to address structural barriers that prevent women from accessing prevention services. This includes improving transportation to health facilities, providing childcare during clinic visits, and ensuring confidential services that protect women’s privacy. Healthcare systems need adequate staffing, consistent drug supplies, and trained providers who can deliver compassionate, non-judgmental care. Integration of prevention services into routine maternal and child health programs makes them more accessible and reduces the burden on women to navigate multiple separate services.

Moving toward elimination 🔗

The global health community has made remarkable progress toward eliminating mother-to-child transmission of HIV. Between 2000 and 2024, approximately 4.4 million children were prevented from acquiring HIV through prevention programs. Several countries have achieved validation for elimination of mother-to-child transmission, demonstrating that elimination is an achievable goal.

However, significant challenges remain. Coverage gaps persist, particularly in reaching adolescent girls and young women who face heightened vulnerability to HIV. Retention in care remains a critical issue, with many women lost to follow-up after their initial contact with prevention services. Almost 65 percent of new HIV infections among children in 2024 occurred because mothers did not receive ART or discontinued treatment during pregnancy or breastfeeding. Strengthening health systems, ensuring continuous engagement throughout the prevention cascade, and addressing social determinants of health will be essential for reaching elimination targets by 2030.

What do you think? How can communities better support pregnant women living with HIV to ensure they stay engaged with prevention services throughout pregnancy and breastfeeding? What role can healthcare providers play in creating more welcoming, stigma-free environments for women seeking these essential services?

References

1. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/prevention/mother-to-child-transmission-of-hiv
2. https://www.ncbi.nlm.nih.gov/books/NBK143052/
3. https://data.unicef.org/topic/hivaids/emtct/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC4470389/
5. https://www.who.int/tools/elena/interventions/hiv-infant-feeding
6. https://www.cdc.gov/breastfeeding-special-circumstances/hcp/illnesses-conditions/hiv.html